ACA
AMGN icon

Aspire Capital Advisors’s Amgen AMGN Stock Holding History

Aspire Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$527K Buy
1,499
+2
+0.1% +$713 0.12% 66
2025
Q4 		$490K Sell
1,497
-42
-3% -$13.3K 0.12% 72
2025
Q3 		$434K Buy
1,539
+11
+0.7% +$3.19K 0.11% 73
2025
Q2 		$427K Sell
1,528
-50
-3% -$14.2K 0.12% 69
2025
Q1 		$492K Buy
1,578
+22
+1% +$6.5K 0.15% 57
2024
Q4 		$406K Sell
1,556
-158
-9% -$46.9K 0.12% 59
2024
Q3 		$552K Sell
1,714
-98
-5% -$32.1K 0.16% 48
2024
Q2 		$566K Buy
1,812
+3
+0.2% +$881 0.19% 43
2024
Q1 		$514K Buy
1,809
+4
+0.2% +$1.17K 0.17% 45
2023
Q4 		$520K Sell
1,805
-8
-0.4% -$2.18K 0.21% 42
2023
Q3 		$487K Buy
1,813
+81
+5% +$20.2K 0.22% 44
2023
Q2 		$385K Buy
1,732
+4
+0.2% +$928 0.19% 45
2023
Q1 		$418K Buy
1,728
+97
+6% +$23.8K 0.22% 39
2022
Q4 		$428K Buy
1,631
+2
+0.1% +$536 0.24% 38
2022
Q3 		$367K Buy
1,629
+4
+0.2% +$970 0.29% 36
2022
Q2 		$395K Buy
1,625
+4
+0.2% +$980 0.3% 35
2022
Q1 		$392K Buy
+1,621
New +$372K 0.37% 31

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Aspire Capital Advisors's AMGN Position: Q1 2026 in Review

Aspire Capital Advisors increased its Amgen (AMGN) stake by 0.13% in Q1 2026, buying an estimated $713 and bringing the position to 1,499 shares worth $527K. The position accounts for 0.12% of the portfolio, ranked #66.

Aspire Capital Advisors first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $566K in Q2 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Aspire Capital Advisors held 1,499 shares of Amgen worth $527K as of Q1 2026.
  • Aspire Capital Advisors bought 2 Amgen shares in Q1 2026, an estimated $713.
  • Amgen made up 0.12% of Aspire Capital Advisors's portfolio in Q1 2026, its #66 holding.
  • Aspire Capital Advisors first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
  • Aspire Capital Advisors's Amgen position peaked at $566K in Q2 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Aspire Capital Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.